These data suggested that high expression of SCAND2, SCAND1, and MZF1 genes were superior prognostic markers in several cancer types, including pancreatic cancer, head and neck cancers, lung adenocarcinoma, sarcoma and cervical cancer. The gene discussed is SCAND1; the disease is head and neck cancer.